_____________________________________________________________________________________________________

A meta-analysis of ivermectin use against Covid-19 praised the drug for its “positive results,” according to the Epoch Times.
Ivermectin, a cheap and readily-available medicine used mostly for its anti-parasitic properties, was heavily demonized by the mainstream media as a “quack” treatment during the 2020 Covid outbreak.
“Over the 63 studies in meta-analysis, pooled effects showed 69% improvement in early treatment,” says reports.”
A meta-analysis of ivermectin use against Covid-19 praised the drug for its “positive results,” according to the Epoch Times.
Ivermectin, a cheap and readily-available medicine used mostly for its anti-parasitic properties, was heavily demonized by the mainstream media as a “quack” treatment during the 2020 Covid outbreak.
“In a meta-analysis of 63 studies of ivermectin versus COVID-19 in humans, 100% of these have shown positive results,” the outlet reported. “Studies were from all continents except Antarctica. Considered individually, 29 of those studies were found to be statistically significant regarding use of ivermectin alone.”
“Over the 63 studies in meta-analysis, pooled effects showed 69% improvement in early treatment, and prophylactic use showed 86% improvement.”
The results of these studies come in direct contrast with the Food and Drug Administration, which stated that “any use of ivermectin for the prevention or treatment of COVID-19 should be avoided as its benefits and safety for these purposes have not been established.”
The FDA claim, as well as its overall handling of the Covid outbreak, led to some critics suggesting the agency was growing too political.
“The FDA offered no supporting evidence for their claim,” the Epoch Times added. “One concerning risk is that ivermectin is sold over the counter for veterinary use, and if people feel desperate to use it to ward off COVID-19, they might break off too large a piece from a large horse pill.”
The controversy over ivermectin put a spotlight on long-standing criticism – predating Covid-19 – that the FDA is a ‘revolving door’ for Big Pharma.